(a) Size distribution of the MCM proteins extracted from soluble and chromatin extracts. Estimated size (using thyroglobulin, 669 kDa; ferritin, 440 kDa; aldolase, 158 kDa; and ovalbumin, 44 kDa) is …
(a) Extracts used for the size fractionation assays. HSP90 and Tubulin were used as soluble protein markers. Histone H2B was used for a chromatin protein marker. (b) All MCM proteins and MCM-binding …
(a) Schematic illustration of MCMBP depletion by the AID2 system. Upon 5-Ph-IAA addition, mAID-Clover (mAC)-tagged MCMBP was recognized by OsTIR1(F74G) for degradation by the proteasome. (b) …
(a) Degradation of MCM-binding protein (MCMBP)-mAC was monitored by microscopy at 4 hr after the addition of 1 μM 5-Ph-IAA. (b) Cell-cycle distribution on Days 1, 2, and 3 after the addition of 1 μM …
(a) Illustration of the MCMBP truncations used in this study. NLS, nuclear localization signal; WB, Walker B; AF, arginine finger. (b) Interaction of MCMBP truncations with MCM3. HCT116 cells were …
(a) Representation of the MCM3 truncates. (b) Interaction of the MCM3 truncates with MCM-binding protein (MCMBP). FLAG-tagged MCM3 truncates were expressed and subjected to immunoprecipitation using …
(a) Size distribution of DD-FLAG-MCM3 in the presence or absence of MCMBP. Proteins were extracted and analyzed by immunoblotting at 6 or 24 hr after the addition of 0.5 μM Shield-1 with or without …
(a) Schematic illustration of the DD-MCM3 system. Ectopic expression of DD-(FLAG or mScarletI)-MCM3 was stabilized in the presence of a ligand, Shield-1. Without Shield-1, the fusion protein is …
(a) The expression of the MCM4-DD was confirmed by immunoblotting using the indicated antibodies. Subcellular localization of MCM4-DD (b) and DD-MCM3 (c) with or without 1 μM of 5-Ph-IAA. In the …
(a) The growth of the indicated cell lines was measured every 2 days after the addition of 1 μM 5-Ph-IAA. Data represent the mean ± standard deviation (SD) of three independent experiments (Day 0 = …
(a) Chromatin-bound MCM2 after MCM-binding protein (MCMBP) depletion to monitor the levels of replication licensing. Soluble proteins were extracted before staining with anti-MCM2 antibody. The …
Figure | Cell line |
---|---|
Figure 1d | HCT116 CMV-OsTIR1F74G Stag-3FLAG-MCM3 |
Figure 2b–d | HCT116 CMV-OsTIR1F74G MCMBP-mAC |
Figure 3c–e, Figure 1—figure supplement 1e | HCT116 CMV-OsTIR1F74G MCMBP-mAC 2HA-MCMBP FL |
Figure 3c–e | HCT116 CMV-OsTIR1F74G MCMBP-mAC 2HA-MCMBPΔN |
Figure 3c–e | HCT116 CMV-OsTIR1F74G MCMBP-mAC 2HA-MCMBPΔNLS |
Figure 4a and f | HCT116 CMV-OsTIR1F74G MCMBP-mAC PiggyBac-EF1-DD-3FLAG-MCM3 |
Figure 4b–e | HCT116 CMV-OsTIR1F74G MCMBP-mAC PiggyBac-EF1-DD-mScarletI-MCM3 |
Figure 5a–e | HCT116 CMV-OsTIR1F74G MCMBP-mAC p53−/− |
Figure 4—figure supplement 2a, d | HCT116 CMV-OsTIR1F74G MCMBP-mAC PiggyBac-EF1-MCM4-3FLAG-DD |
Figure 4—figure supplement 2b | HCT116 CMV-OsTIR1F74G MCMBP-mAC PiggyBac-EF1-MCM4-mScarletI-DD |
Figure | Plasmid |
---|---|
Figure 1d | MCM3-N-tagging CRISPR in pX330 |
Figure 1d | Stag-3FLAG-N-MCM3 donor |
Figure 2b | MCMBP-C-tagging CRISPR in pX330 |
Figure 2b | MCMBP-C-tagging CRISPR in pX330 |
Figure 3a, b | CMV-2HA-MCMBP FL |
Figure 3a, b | CMV-2HA-MCMBPΔN |
Figure 3a, b | CMV-2HA-MCMBPΔNLS |
Figure 3a, b | CMV-2HA-MCMBPΔmid |
Figure 3a, b | CMV-2HA-MCMBPΔC |
Figure 3c–e, Figure 1—figure supplement 1e | Piggy–Bac-EF1-2HA-MCMBP FL |
Figure 3c–e | PiggyBac-EF1-2HA-MCMBPΔN |
Figure 3c–e | PiggyBac-EF1-2HA-MCMBPΔNLS |
Figure 4a, f | PiggyBac-EF1-DD-3FLAG-MCM3 |
Figure 4b–e | PiggyBac-EF1-DD-mScarletI-MCM3 |
Figure 5a–e | TP53-KO CRISPR in pX330 |
Figure 3—figure supplement 1a, b | TP53-KO CRISPR in pX330 |
Figure 3—figure supplement 1a, b | PiggyBac-EF1-3FLAG-MCM3 FL |
Figure 3—figure supplement 1a, b | PiggyBac-EF1-3FLAG-MCM3ΔN |
Figure 3—figure supplement 1a, b | PiggyBac-EF1-3FLAG-MCM3ΔMCM |
Figure 4—figure supplement 2a, d | PiggyBac-EF1-3FLAG-MCM3ΔC |
Figure 4—figure supplement 2b | PiggyBac-EF1-MCM4-3FLAG-DD |
Antigen | Manufacturer | Code | Method(s) | Dilution(s) |
---|---|---|---|---|
MCM2 | CST | 3619 | IB and IF | 1:10,000 for IB; 1:1000 for IF |
MCM3 | Proteintech | 15597-1-AP | IB | 1:5000 |
MCM4 | Abcam | ab4459 | IB | 1:5000 |
MCM5 | Proteintech | 11703-1-AP | IB | 1:3000 |
MCM6 | Proteintech | 13347-2-AP | IB | 1:5000 |
MCM7 | Proteintech | 11225-1-AP | IB | 1:5000 |
MCMBP | Proteintech | 19573-1-AP | IB | 1:5000 |
FLAG | SIGMA | F1804 | IB | 1:10,000 |
HA | MBL | M132-3 | IB | 1:5000 |
HSP90 | Proteintech | 60,318 | IB | 1:5000 |
Tubulin | BioRad | 12004165 | IB | 1:10,000 |
histone H2B | Abcam | ab1790 | IB | 1:10,000 |
p53 | MBL | K0181-3 | IB | 1:5000 |
p21 | CST | 2946 | IB | 1:3000 |
gH2AX | Millipore | 05-636 | IB | 1:3000 |
anti-rabbit IgG | Abcam | ab216773 | IB | 1:3000 |
anti-mouse IgG | Abcam | ab216772 | IB | 1:3000 |
anti-mouse IgG | BioRad | 12004158 | IB | 1:3000 |
anti-rabbit IgG | BioRad | 12004161 | IB | 1:3000 |
anti-rabbit IgG | Life Technologies | A-11037 | IF | 1:500 |
anti-mouse IgG | Life Technologies | A-21236 | IF | 1:500 |
Underlying data for all graphs.
All original immunoblot images.